Current status of lung cancer screening

Thoracic Surgery Clinics

Volumn 23, Issue 2, 2013, Pages 129-140

  Pastorino, Ugo ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Biomarkers; Early detection; Low dose computed tomography; Lung cancer screening; Overdiagnosis

Indexed keywords

ALGORITHM; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE MARKER; FALSE POSITIVE RESULT; HEALTH PROGRAM; HISTOPATHOLOGY; HUMAN; LIFE EXPECTANCY; LUNG CANCER; MORBIDITY; MORTALITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; OBSERVATIONAL STUDY; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; RISK ASSESSMENT; SMOKING;

AGED; BIOLOGICAL MARKERS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; MICRORNAS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL RATE; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 84875900863     PISSN: 15474127     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2013.01.018     Document Type: Review

References (75)

1. Peto R., Lopez A.D., Boreham J., et al. Mortality from smoking worldwide. Br Med Bull 1996, 52:12-21.
2. Jemal A., Siegel R., Xu J., et al. Cancer statistics, 2010. CA Cancer J Clin 2010, 60(5):277-300.
3. Yang L., Parkin D.M., Li L.D., et al. Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br J Cancer 2004, 90:2157-2166.
4. Levi F., Lucchini F., Negri E., et al. Mortality from major cancer sites in the European Union, 1955-1998. Ann Oncol 2003, 14:490-495.
5. Verdecchia A., Franceschi S., Brenner H., et al. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE 4 data. Lancet Oncol 2007, 8:784-796.
6. Howlander N, Noone AM, Krapcho M, et al, editors. SEER Cancer statistics review, 1975-2008. Bethesda (MD): National Cancer Institute.
7. Goldstraw P., Crowley J., Chansky K., et al. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007, 2:706-714.
8. Melamed M.R., Flehinger B.J., Zaman M.B., et al. Screening for lung cancer: results of the Memorial Sloan-Kettering study in New York. Chest 1984, 86:44-53.
9. Tockman M.S. Survival and mortality from lung cancer in a screened population. Chest 1986, 89(Suppl 4):324S-325S.
10. Prorok P.C., Andriole G.L., Bresalier R.S., Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team, et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening trial. Control Clin Trials 2000, 21(Suppl 6):273S-309S.
11. Melamed M.R. Lung cancer screening results in the National Cancer Institute New York study. Cancer 2000, 89(Suppl 11):2356-2362.
12. Kubik A., Polak J. Lung cancer detection: results of a randomized prospective study in Czechoslovakia. Cancer 1986, 57(12):2427-2437.
13. Marcus P.M., Bergstralh E.J., Zweig M.H., et al. Extended lung cancer incidence follow-up in the Mayo lung project and overdiagnosis. J Natl Cancer Inst 2006, 98:748-756.
14. Kaneko M., Eguchi K., Ohmatsu H., et al. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 1996, 201:798-802.
15. Henschke C.I., McCauley D.I., Yankelevitz D.F., et al. Early lung cancer action project: overall design and findings from baseline screening. Lancet 1999, 354:99-105.
16. Sone S., Li F., Yang Z.G., et al. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer 2001, 84:25-32.
17. Nawa T., Nakagawa T., Kusano S., et al. Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies. Chest 2002, 122:15-20.
18. Sobue T., Moriyama N., Kaneko M., et al. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol 2002, 20:911-920.
19. Swensen S.J., Jett J.R., Hartman T.E., et al. Lung cancer screening with CT: Mayo Clinic experience. Radiology 2003, 226:756-761.
20. Pastorino U., Bellomi M., Landoni C., et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003, 362:593-597.
21. Diederich S., Thomas M., Semik M., et al. Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers. Eur Radiol 2004, 14:691-702.
22. Bastarrika G., García-Velloso M.J., Lozano M.D., et al. Early lung cancer detection using spiral computed tomography and positron emission tomography. Am J Respir Crit Care Med 2005, 171:1378-1383.
23. Chong S., Lee K.S., Chung M.J., et al. Lung cancer screening with low-dose helical CT in Korea: experiences at the Samsung Medical Center. J Korean Med Sci 2005, 20:402-408.
24. Novello S., Fava C., Borasio P., et al. Three-year findings of an early lung cancer detection feasibility study with low-dose spiral computed tomography in heavy smokers. Ann Oncol 2005, 16:1662-1666.
25. MacRedmond R., McVey G., Lee M., et al. Screening for lung cancer using low dose CT scanning: results of 2 year follow up. Thorax 2006, 61:54-56.
26. The International Early Lung Cancer Action Program Investigators (I-ELCAP) Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006, 355:1763-1771.
27. Callol L., Roig F., Cuevas A., et al. Low-dose CT: a useful and accessible tool for the early diagnosis of lung cancer in selected populations. Lung Cancer 2007, 56(2):217-221.
28. Veronesi G., Bellomi M., Mulshine J.L., et al. Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules. Lung Cancer 2008, 61:340-349.
29. Wilson D.O., Weissfeld J.L., Fuhrman C.R., et al. The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med 2008, 178(9):956-961.
30. Menezes R.J., Roberts H.C., Paul N.S., et al. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience. Lung Cancer 2010, 67(2):177-183.
31. Gohagan J.K., Marcus P.M., Fagerstrom R.M., The Lung Screening Study Research Group, et al. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer 2005, 47:9-15.
32. Infante M., Lutman F.R., Cavuto S., DANTE Study Group, et al. Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial. Lung Cancer 2008, 59:355-363.
33. Clark K.W., Gierada D.S., Marquez D., et al. Collecting 48,000 CT exams for the Lung Screening Study of the National Lung Screening Trial. J Digit Imaging 2008, 22(6):667-680.
34. van den Bergh K.A., Essink-Bot M.L., Bunge E.M., et al. Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial). Cancer 2008, 113:396-404.
35. Lopes Pegna A., Picozzi G., Mascalchi M., ITALUNG Study Research Group, et al. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer 2009, 64(1):34-40.
36. Pedersen J.H., Ashraf H., Dirksen A., et al. The Danish randomized lung cancer CT screening trial-overall design and results of the prevalence round. J Thorac Oncol 2009, 4:608-614.
37. Pastorino U. Early detection of lung cancer. Respiration 2006, 73:5-13.
38. Becker N., Motsch E., Gross M.L., et al. Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round. J Cancer Res Clin Oncol 2012, 138(9):1475-1486.
39. Oken M.M., Hocking W.G., Kvale P.A., PLCO Project Team, et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA 2011, 306(17):1865-1873.
40. Becker N., Delorme S., Kauczor H.U. LUSI: the German component of the European trial on the efficacy of multislice-CT for the early detection of lung cancer. Onkologie 2008, 31:PO320.
41. Gohagan J.K., Marcus P.M., Fagerstrom R.M., et al. The Lung Screening Study: the National Cancer Institute's randomized feasibility study of spiral CT versus chest X-ray in lung cancer screening. Chest 2004, 126:114-121.
42. Blanchon T., Bréchot J.M., Grenier P.A., "Dépiscan" Group, et al. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer 2007, 58:50-58.
43. Field J.K., Baldwin D., Brain K., UKLS Team, et al. CT screening for lung cancer in the UK: position statement by UKLS investigators following the NLST report. Thorax 2011, 66(8):736-737.
44. van Klaveren R.J., Oudkerk M., Prokop M., et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009, 361:2221-2229.
45. Infante M., Cavuto S., Lutman F.R., DANTE StudyGroup*, et al. A randomized study of lung cancer screening with spiral computed tomography (The DANTE Trial) three-year results. Am J Respir Crit Care Med 2009, 180:445-453.
46. Kramer B.S., Berg C.D., Aberle D.R., et al. Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST). J Med Screen 2011, 18:109-111.
47. Saghir Z., Dirksen A., Ashraf H., et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax 2012, 67:296-301.
48. Pastorino U., Rossi M., Rosato V., et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 2012, 21:308-315.
49. Swensen S.J., Jett J.R., Hartman T.E., et al. CT screening for lung cancer: five-year prospective experience. Radiology 2005, 235:259-265.
50. Wiemker R., Rogalla P., Blaffert T., et al. Aspects of computer-aided detection (CAD) and volumetry of pulmonary nodules using multislice CT. Br J Radiol 2005, 78:S46-S56.
51. Marchianò A., Calabrò E., Civelli E., et al. Pulmonary nodules: volume repeatability at multidetector CT lung cancer screening. Radiology 2009, 251:919-925.
52. Libby D.M., Smith J.P., Altorki N.K., et al. Managing the small pulmonary nodule discovered by CT. Chest 2004, 125:1522-1529. [review].
53. Henschke C.I., Yankelevitz D.F., Mirtcheva R., ELCAP Group, et al. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 2002, 178:1053-1057.
54. Gould M.K., Maclean C.C., Kuschner W.G., et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001, 285:914-924.
55. Kim S.K., Allen-Auerbach M., Goldin J., et al. Accuracy of PET/CT in characterization of solitary pulmonary lesions. J Nucl Med 2007, 48:214-220.
56. van Tinteren H., Hoekstra O.S., Smit E.F., PLUS study group*, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 2002, 359:1388-1392.
57. Veronesi G., Bellomi M., Veronesi U., et al. Role of positron emission tomography scanning in the management of lung nodules detected at baseline computed tomography screening. Ann Thorac Surg 2007, 84:959-966.
58. Pastorino U., Landoni C., Marchianò A., et al. Fluorodeoxyglucose (FDG) uptake measured by positron emission tomography (PET) and standardised uptake value (SUV) predicts long-term survival of CT screening-detected lung cancer in heavy smokers. J Thorac Oncol 2009, 11:1352-1356.
59. Bianchi F., Hu J., Pelosi G., et al. Lung cancers detected by screening with spiral computed tomography have a malignant phenotype when analyzed by cDNA microarray. Clin Cancer Res 2004, 10:6023-6028.
60. Travis D.L., Travis L.B., Devesa S.S. Lung cancer. Cancer 1995, 75:191-202.
61. Vazquez M., Carter D., Brambilla E., The International Early Lung Cancer Action Program Investigators, et al. Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications. Lung Cancer 2009, 64(2):148-154.
62. Silva M., Sverzellati N., Manna C., et al. Long-term surveillance of ground glass nodules. Evidence from the MILD Trial. J Thorac Oncol 2012, 7(10):1541-1546.
63. Welch H.G., Black W.C. Overdiagnosis in cancer. J Natl Cancer Inst 2010, 102:605-613.
64. Esserman L., Thompson I. Solving the overdiagnosis dilemma. J Natl Cancer Inst 2010, 102:582-583.
65. Bach P.B., Jett J.R., Pastorino U., et al. Computed tomography screening and lung cancer outcomes. JAMA 2007, 297:953-961.
66. Bach P.B., Mirkin J.N., Oliver T.K., et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012, 307:2418-2429.
67. Stiles BM, Stowe CW, Mirza FM, et al. Cumulative radiation dose from medical imaging procedures in patients undergoing resection for lung cancer. Proceedings of the 47th Annual Meeting of the Society of Thoracic Surgeons, San Diego, February 1, 2011.
68. Iorio M.V., Croce C.M. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 2012, 4:143-159.
69. Mitchell P.S., Parkin R.K., Kroh E.M., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008, 105:10513-10518.
70. Boeri M., Verri C., Conte D., et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A 2011, 108:3713-3718.
71. Bianchi F., Nicassio F., Marzi M., et al. A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol Med 2011, 3:495-503.
72. Lam S., Boyle P., Healey G.F., et al. Early CDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer. Cancer Prev Res (Phila) 2011, 4:1126-1134.
73. Pecot C.V., Li M., Zhang X.J., et al. Added value of a serum proteomic signature in the diagnostic evaluation of lung nodules. Cancer Epidemiol Biomarkers Prev 2012, 21:786-792.
74. Aberle D.R., Adams A.M., Berg C.D., The National Lung Screening Trial Research Team, et al. Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst 2010, 102(23):1771-1779.
75. Bassler D., Briel M., Montori V.M., STOPIT-2 Study Group, et al. Stopping randomized trials early for benefit and estimation of treatment effect. Systematic review and meta-regression analysis. JAMA 2010, 303:1180-1187.